Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 3, 2015, Pages 109.e15-109.e22

  Feng, Tom S ^a   Sharif Afshar, Ali Reza ^a   Smith, Steven C ^a   Miller, Joseph ^a   Nguyen, Christopher ^a   Li, Quanlin ^a   Luthringer, Daniel ^a   Li, Debiao ^a   Saouaf, Rola ^a   Kim, Hyung L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cancer staging; Extracapsular extension; Magnetic resonance imaging; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLOGICAL PARAMETERS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER EXTRACAPSULAR EXTENSION; PROSTATECTOMY; RADIOLOGIST; SENSITIVITY AND SPECIFICITY; AGED; CANCER GRADING; METABOLISM; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; REPRODUCIBILITY; SEMINAL VESICLE;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEMINAL VESICLES;

EID: 84925362672     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.11.007     Document Type: Article

References (17)

1. Mikel Hubanks J., Boorjian S.A., Frank I., Gettman M.T., Houston Thompson R., Rangel L.J., et al. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. Urol Oncol 2014, 32:26. (e1-7).
2. Tollefson M.K., Karnes R.J., Rangel L.J., Bergstralh E.J., Boorjian S.A. The impact of clinical stage on prostate cancer survival following radical prostatectomy. J Urol 2013, 189:1707-1712.
3. Billis A., Meirelles L.L., Freitas L.L., Magna L.A., Reis L.O., Ferreira U. Influence of focal and diffuse extraprostatic extension and positive surgical margins on biochemical progression following radical prostatectomy. Int Braz J Urol 2012, 38:175-184.
4. Epstein J.I., Carmichael M.J., Pizov G., Walsh P.C. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 1993, 150:135-141.
5. Partin A.W., Borland R.N., Epstein J.I., Brendler C.B. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 1993, 150:142-146. [discussion 6-8].
6. Roethke M.C., Lichy M.P., Kniess M., Werner M.K., Claussen C.D., Stenzl A., et al. Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy. World J Urol 2013, 31:1111-1116.
7. Cerantola Y., Valerio M., Kawkabani Marchini A., Meuwly J.Y., Jichlinski P. Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?. Can Urol Assoc J 2013, 7:E699-E703.
8. Somford D.M., Hamoen E.H., Futterer J.J., van Basten J.P., Hulsbergen-van de Kaa C.A., Vreuls W., et al. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. J Urol 2013, 190:1728-1734.
9. Barentsz J.O., Richenberg J., Clements R., Choyke P., Verma S., Villeirs G., et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012, 22:746-757.
10. Samaratunga H., Montironi R., True L., Epstein J.I., Griffiths D.F., Humphrey P.A., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2011, 24:6-15.
11. Magi-Galluzzi C., Evans A.J., Epstein J.I., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2011, 24:26-38.
12. Fine S.W., Amin M.B., Berney D.M., et al. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol 2012, 62:20-29.
13. Pak S., Park S., Ryu J., Hong S., Song S.H., You D., et al. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean J Urol 2013, 54:824-829.
14. Cooperberg M.R., Lubeck D.P., Mehta S.S., Carroll P.R. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol 2003, 170:S21-S25. CaPsure, [discussion S6-7].
15. Han M., Partin A.W., Piantadosi S., Epstein J.I., Walsh P.C. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001, 166:416-419.
16. Eifler J.B., Feng Z., Lin B.M., Partin M.T., Humphreys E.B., Han M., et al. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int 2013, 111:22-29.
17. Sankin A., Tareen B., Lepor H. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy. Prostate Cancer Prostatic Dis 2009, 12:204-208.